Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M M Oken

Showing results (31-40 of 148) with videos related to

Pageof 15
Sort By:
American Journal of Hematology|December 1, 1981
Auer rod positive dysmyelopoietic syndromeD J Weisdorf, M M Oken, G J Johnson, et al.
Archives of Internal Medicine|August 1, 1973
Possible NZB syndrome in manM M Oken, R W Griffiths, R C Williams, et al.
British Journal of Haematology|December 1, 1983
Chronic myelodysplastic syndrome: short survival with or without evolution to acute leukaemiaD J Weisdorf, M M Oken, G J Johnson, et al.
Nouvelle Revue Francaise D'Hematologie|January 1, 1988
Evidence for tumor reduction in refractory or relapsed B-CLL patients with infusional interleukin-2N E Kay, M M Oken, J J Mazza, et al.
Nouvelle Revue Francaise D'Hematologie|January 1, 1988
The prognosis and therapy of chronic lymphocytic leukemia under age 50 yearsJ M Bennett, B Raphael, M M Oken, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 1, 1992
Survival after relapse of low-grade non-Hodgkin's lymphoma: implications for marrow transplantationD J Weisdorf, J W Andersen, J H Glick, et al.
Life Sciences|December 12, 1983
Thermoregulatory effects of purines and caffeineS A Wager-Srdar, M M Oken, J E Morley, et al.
Peptides|January 1, 1982
Neuropeptides and thermoregulation: the interactions of bombesin, neurotensin, TRH, somatostatin, naloxone and prostaglandinsJ E Morley, A S Levine, M M Oken, et al.
Investigational New Drugs|January 1, 1996
A phase II trial of amonafide, caracemide, and homoharringtonine in the treatment of patients with advanced renal cell cancerR S Witte, P Hsieh, P Elson, et al.
Medical and Pediatric Oncology|January 1, 1985
Simultaneous presentation of relapsing Hodgkin's disease and treatment-related non-Hodgkin's lymphomaR T Perri, J I Allen, M M Oken, et al.
Pageof 15

Showing results (31-40 of 148) with videos related to

Sort By:
Pageof 15
American Journal of Hematology|December 1, 1981
Auer rod positive dysmyelopoietic syndromeD J Weisdorf, M M Oken, G J Johnson, et al.
Archives of Internal Medicine|August 1, 1973
Possible NZB syndrome in manM M Oken, R W Griffiths, R C Williams, et al.
British Journal of Haematology|December 1, 1983
Chronic myelodysplastic syndrome: short survival with or without evolution to acute leukaemiaD J Weisdorf, M M Oken, G J Johnson, et al.
Nouvelle Revue Francaise D'Hematologie|January 1, 1988
Evidence for tumor reduction in refractory or relapsed B-CLL patients with infusional interleukin-2N E Kay, M M Oken, J J Mazza, et al.
Nouvelle Revue Francaise D'Hematologie|January 1, 1988
The prognosis and therapy of chronic lymphocytic leukemia under age 50 yearsJ M Bennett, B Raphael, M M Oken, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 1, 1992
Survival after relapse of low-grade non-Hodgkin's lymphoma: implications for marrow transplantationD J Weisdorf, J W Andersen, J H Glick, et al.
Life Sciences|December 12, 1983
Thermoregulatory effects of purines and caffeineS A Wager-Srdar, M M Oken, J E Morley, et al.
Peptides|January 1, 1982
Neuropeptides and thermoregulation: the interactions of bombesin, neurotensin, TRH, somatostatin, naloxone and prostaglandinsJ E Morley, A S Levine, M M Oken, et al.
Investigational New Drugs|January 1, 1996
A phase II trial of amonafide, caracemide, and homoharringtonine in the treatment of patients with advanced renal cell cancerR S Witte, P Hsieh, P Elson, et al.
Medical and Pediatric Oncology|January 1, 1985
Simultaneous presentation of relapsing Hodgkin's disease and treatment-related non-Hodgkin's lymphomaR T Perri, J I Allen, M M Oken, et al.
Pageof 15